A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
R&D Accounting Treatment, R&D State and Tax Avoidance: With a Focus on Biotech Firms
This study examines the correlation among R&D accounting treatment, R&D state and tax avoidance behavior, with a focus on biotech firms. Findings from the analysis show that most firms are unlikely to capitalize R&D in a steady state; however, in the case of biotech firms, this is not the case. This may be due to biotech firms’ accounting choice to capitalize R&D outlays based on a strong belief in future opportunities of commercial success. Moreover, the analysis of tax avoidance behavior finds that firms with low capitalization in an R&D steady state have a positive correlation with tax avoidance, whereas biotech firms do not. The results imply that biotech firms focus on sustainable commercial success unlike the general patterns of other industries.
R&D Accounting Treatment, R&D State and Tax Avoidance: With a Focus on Biotech Firms
This study examines the correlation among R&D accounting treatment, R&D state and tax avoidance behavior, with a focus on biotech firms. Findings from the analysis show that most firms are unlikely to capitalize R&D in a steady state; however, in the case of biotech firms, this is not the case. This may be due to biotech firms’ accounting choice to capitalize R&D outlays based on a strong belief in future opportunities of commercial success. Moreover, the analysis of tax avoidance behavior finds that firms with low capitalization in an R&D steady state have a positive correlation with tax avoidance, whereas biotech firms do not. The results imply that biotech firms focus on sustainable commercial success unlike the general patterns of other industries.
R&D Accounting Treatment, R&D State and Tax Avoidance: With a Focus on Biotech Firms
Namryoung Lee (author)
2018
Article (Journal)
Electronic Resource
Unknown
Metadata by DOAJ is licensed under CC BY-SA 1.0
Differences in Tax Avoidance According to Corporate Sustainability with a Focus on Delisted Firms
| DOAJ | 2022
Demographics, Innovative Outputs and Alliance Strategies of Canadian Biotech Firms
| Online Contents | 2010
Demographics, Innovative Outputs and Alliance Strategies of Canadian Biotech Firms
| Taylor & Francis Verlag | 2010
International Strategy, R&D Intensity, and Sustainable Earnings of Biotech Firms
| DOAJ | 2019